#ESCCongress | Diretrizes 2021 da ESC/EACTS para tratamento da doença cardíaca valvar – Nas novas diretrizes, mais pacientes são elegíveis a intervenções cirúrgicas e transcateter, com base não somente nos sintomas, mas também em critérios de imagem.
30 Ago, 2021 | 13:27hComunicado de imprensa: European valvular heart disease Guidelines published today – European Society of Cardiology
Resumo: 2021 ESC/EACTS Valvular Heart Disease Guidelines: Key Points – American College of Cardiology
Comentário: Revamped Valve Disease Guideline: Europe Sees Nearly Eye to Eye With U.S. – MedPage Today (necessário cadastro gratuito)
“In line with recent U.S. recommendations, the newest European guidelines favor a wider pool of patients eligible for surgical and transcatheter interventions for valvular heart disease.” (from MedPage Today)
Comentários no Twitter
#ESCCongress new VHD guidelines out ➡️https://t.co/fFkuivAM9E
➡️SAVR in low risk pts <75yrs old
➡️ TAVR in pts >75
➡️ Role of heart team emphasised
➡️ NEW! intervention to be considered with asymptomatic AS with lv <55% IIa@HanCardiomd @Hragy @aayshacader @DrMarthaGulati #TAVR pic.twitter.com/JV1zocQJaK— Mamas Mamas (@mmamas1973) August 28, 2021
🆕Guidelines for the management of valvular heart disease #ESCCongress @escardio @secardiologia @EACTS
📂 https://t.co/3FCS8YYKIr @mmamas1973 @shci_sec pic.twitter.com/wxuf3AjVaE
— Alfonso Valle (@ValleAlfonso) August 28, 2021
Optimal antithrombotic therapy for valve prostheses from the 2021 #ESC Guidelines for the management of VHD #ESCCongress @escardio https://t.co/AmQJkZBMoo pic.twitter.com/WK2wQSSlhL
— Roxana Mehran (@Drroxmehran) August 28, 2021
(thread – click for more)
Have there been changes in when to intervene with the new 2021 ESC/EACTS guidelines for the management of valvular heart disease?
Yes, and in general the bar for intervention is now lower
Thread follows…#ESCCongress
1/n pic.twitter.com/iLN9cLCtLj
— Sarah Hudson (@sarahhudsonuk) August 28, 2021